Repurposing auranofin and meclofenamic acid as energy-metabolism inhibitors and anti-cancer drugs.
Sara Rodríguez-EnríquezDiana Xochiquetzal Robledo-CadenaSilvia Cecilia Pacheco-VelázquezJorge Luis Vargas-NavarroJoaquín Alberto Padilla-FloresTuuli KaambreRafael Moreno-SánchezPublished in: PloS one (2024)
Aur surges as a highly promising anticancer drug, suggesting that efforts to establish this drug in the clinical treatment protocols are warranted and worthy to undertake.